Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

Since its introduction in the 1990s, liposomal amphotericin B (LAmB) continues to be an important agent for the treatment of invasive fungal diseases caused by a wide variety of yeasts and molds. This liposomal formulation was developed to improve the tolerability of intravenous amphotericin B, whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495018/
https://www.ncbi.nlm.nih.gov/pubmed/31222253
http://dx.doi.org/10.1093/cid/ciz076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495018/
https://www.ncbi.nlm.nih.gov/pubmed/31222253
http://dx.doi.org/10.1093/cid/ciz076

Ejemplares similares